Lantheus vs Neogen
Lantheus reported revenue of $1.5 billion in fiscal 2025, 1.8 times Neogen's $870 million in fiscal 2026. Lantheus' revenue grew 0.5% in its latest year, and Neogen's fell 2.7%. Lantheus had an operating margin of 20.2%, against -2.5% at Neogen. Free cash flow was $354 million at Lantheus and $32 million at Neogen. Their fiscal years end in different months (December 31 and May 31), so the periods don't line up exactly.
Side by side
| Lantheus | Neogen | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, May 31, 2026 |
| Revenue | $1.5B | $870M |
| Revenue growth | 0.5% | −2.7% |
| Revenue growth a year, last 5 years | 35.3% | 13.2% |
| Gross margin | 61.1% | 46.9% |
| Operating margin | 20.2% | −2.5% |
| Net margin | 15.2% | −0.9% |
| Free cash flow | $354M | $32M |
| Free cash flow margin | 23.0% | 3.7% |
| Return on capital | 22.7% | −0.6% |
| Net debt to EBITDA | 0.6x | 6.4x |
| Dividends and buybacks | $300M | $0M |
| Change in diluted share count | −4.5% | 0.3% |
| Last close | $100.61 | $11.76 |
| P/E at the last close | 24.8× | — |
| Insider trades, last 12 months | — | bought $6,386, sold $114,676 |
| Piotroski F-score | 5 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
LantheusNeogen
Operating margin
Percent of revenue
LantheusNeogen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
LantheusNeogen